Evidence map›Paper›PMID 38277762›Full record

ArticleSocial science & medicine (1982)2024

Understanding the delivery of substance use treatment services to transgender and gender-diverse people: Findings from a mixed-methods study of healthcare professionals.

Jaclyn M W Hughto, Hill L Wolfe, Haley Adrian, Don Operario, Landon D Hughes, Yohansa Fernández, Victoria Briody, Paige Matthews, Patrick J A Kelly, Alexandra B Collins

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Social science & medicine (1982), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jaclyn M W HughtoDepartment of Behavioral and Social Sciences, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA; Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA; Center for Promotion and Health Equity, Brown University, Box G-S121-4, Providence, RI, 02912, USA; The Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA. Electronic address: jaclyn_hughto@brown.edu.
Hill L WolfeDepartment of Health Law, Policy and Management, Boston University School of Public Health, 715 Albany Street, Boston, MA, 02118, USA.
Haley AdrianCenter for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI, 02903, USA.
Don OperarioDepartment of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30329, USA.
Landon D HughesDepartment of Health Behavior and Health Education, University of Michigan School of Public Health, 415 Washington Heights, Ann Arbor, MI, 48109, USA; Institute for Social Research, University of Michigan, 426 Thompson St, Ann Arbor, MI, 48104, USA.
Yohansa FernándezDepartment of Behavioral and Social Sciences, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA; Warren Alpert School of Medicine, for Brown University, 222 Richmond Street, Providence, RI, 02903, USA.
Victoria BriodyWarren Alpert School of Medicine, for Brown University, 222 Richmond Street, Providence, RI, 02903, USA.
Paige MatthewsPacific University, 2043 College Way, Forest Grove, OR, 97116, USA.
Patrick J A KellyDepartment of Behavioral and Social Sciences, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA.
Alexandra B CollinsDepartment of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA.
Brown University · USBoston University · USEmory University · USMichigan Department of Health and Human Services · USPacific University Oregon · US

Funding

Project 4: Neonatal Abstinence Syndrome (NAS): Fetus to First YearsP20GM125507 · NIGMS · RHODE ISLAND HOSPITAL · PI Brandon David Lewis Marshall · 2018 to 2026
$23.4M
TRAINING IN SOCIAL AND ECONOMIC DEMOGRAPHYT32HD007339 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sarah A. Burgard · 1987 to 2026
$14.9M
Training in Child/Adolescent Biobehavioral HIV ResearchT32MH078788 · NIMH · RHODE ISLAND HOSPITAL · PI LARRY K BROWN · 2007 to 2026
$6.2M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
NIGMS NIH HHS P20 GM125507NIMHD NIH HHS L60 MD012898NIMH NIH HHS R25 MH067127NIMH NIH HHS T32 MH078788
6 · The paper itself

Abstract

backgroundTransgender and gender diverse (TGD) people who use drugs report barriers to accessing substance use treatment, including provider mistreatment. Little research has explored the multilevel factors that shape the capacity of substance use treatment professionals to provide gender-affirmative care (i.e., care that respects and affirms one's gender) to TGD people.

methodsFrom October 2021 to March 2022, substance use treatment and harm reduction professionals in Rhode Island were surveyed (N = 101) and qualitatively interviewed (N = 19) about the provision of substance use treatment-related services to TGD people. Quantitative data were analyzed descriptively; differences were examined using Fisher exact tests (p < 0.05). Qualitative interviews were coded and analyzed using thematic analysis.

resultsParticipants reported limited exposure to TGD people and lacked training on TGD health, which resulted in limited cultural and clinical competency and low self-efficacy in their ability to care for TGD people. Participants also highlighted structural factors (e.g., non-inclusive intake forms, limited availability of gender-inclusive ancillary community services) that restricted their ability to provide effective and affirming care to TGD people. Some participants also reported a "gender blind" ethos at their institutions- described by some as ignoring the potential impact of TGD peoples' unique experiences on their substance use and ability to benefit from treatment. While some perceived gender blindness as problematic, others believed this approach enabled substance use treatment professionals to consider all the identities and needs that patients/clients may have. Despite differences in treatment approaches, most participants agreed that their workplaces could benefit from efforts to create a safe and affirming space for people who use drugs, particularly TGD patients/clients.

conclusionResults underscore how structural, interpersonal, and individual factors contributed to barriers in the provision of gender-affirmative substance use-related care for TGD people. Findings can inform efforts to increase the capacity of providers to deliver gender-affirmative substance use-related services, which is essential to supporting the recovery goals of TGD people.

Indexed as

Substance-Related DisordersTransgender PersonsClinical CompetenceFemaleGender-Affirming CareGender IdentityHealth PersonnelHumansMale

Identifiers

PMID38277762
PMCPMC10923070
OpenAlexW4391070075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.